Monograph Capital Holdings Advisors, LLC - Jun 5, 2025 SCHEDULE 13D/A Report for UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)

Filing Manager
Monograph Capital Holdings Advisors, LLC
Reporting Manager
Monograph Capital Partners I, L.P.
Security
UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share
Symbol
URGN
Shares outstanding
46.6M shares
Disclosed Ownership
839K shares
Ownership
1.8%
Form type
SCHEDULE 13D/A
Date filed
6/9/2025, 07:19 PM
Date of event
Jun 5, 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Monograph Capital Partners I, L.P. 1.8% 839K 0 839K /s/ Michael LaGatta Michael LaGatta / Partner and Authorized Signatory 0001864082
Monograph Capital Partners I GenPar, LP 1.8% 839K 0 839K /s/ Michael LaGatta Michael LaGatta / Partner and Authorized Signatory
Monograph Capital Holdings Advisors, LLC 1.8% 839K 0 839K /s/ Michael LaGatta Michael LaGatta / Partner and Authorized Signatory 0001988760
Fred Cohen 1.9% 839K 15K 839K /s/ Michael LaGatta Michael LaGatta/ Attorney-in-fact (1) 0001339358
Charles Conn 1.8% 839K 0 839K /s/ Michael LaGatta Michael LaGatta/ Attorney-in-fact (2)